Guest Column: Are We About to Finally Lower Drug Costs?

Part D Benefit Restructuring Reduces Out-Of-Pocket Exposure, Changes Risk to Prescription Coverage Access and Choice

Prescription drug coverage in Medicare, provided via private health insurance plans under Part D, covers more than 53 million Americans. The Part D benefit—first available in 2006—has undergone significant policy changes in its nearly 20-year history. As initially designed, Part D left beneficiaries with substantial out-of-pocket cost obligations; they were responsible for the full cost of their drugs during a deductible period, faced cost shari…

Guest Column: Are we about to finally lower drug costs?

Americans have been clamoring for sensible prescription drug reform for years. With the stroke of his pen, President Donald Trump answered that call.

Inflation Reduction Act’s Impact on Drug Costs, Patient Abandonment

IQVIA’s Lead Director of Research Michael Kleinrock discusses how federal policy has been impacting prescription drug costs in the US and where those trends are expected to go.

The Uncertain Future of Medicare’s Stand-Alone Prescription Drug Plan Market and Why It Matters – RamaOnHealthcare

Ahead of Medicare’s annual mid-year announcement about the national average premium for Part D prescription drug coverage in 2026 and other plan details, two questions loom large for the insurers that sponsor Part D stand-alone prescription drug plans (PDPs) and the 23 million people in traditional Medicare who are currently enrolled in these plans: Will [...]